HCXY

Hercules Capital, Inc. 6.25% Notes due 2033

$25.03 +0.02%

Recent alerts on HCXY

All signals →

News Hercules Capital (HTGC) Q2 Earnings Meet Estimates, Costs Up

News Eloxx Pharmaceuticals secures $3.2 million in additional funding - Investing.com

SEC filing HCXY Reports $1.81B New Debt/Equity Commitments, $706.4M Fundings, $141.5M Investment Income, 18.4% YoY Growth, 120% NII Coverage, $1.0B Liquidity, 21.8% AUM Increase

Insider trade Purchase by Christian Follmann (Chief Operating Officer)

Insider trade Purchase by Christian Follmann (Chief Operating Officer)

Insider trade Purchase by Paramjeet K Randhawa

Insider trade Purchase by Scott Bluestein (Chief Executive Officer)

Insider trade Purchase by Seth H Meyer (Chief Financial Officer)

Insider trade Purchase by Thomas J Fallon

Insider trade Purchase by Kiersten Zaza Botelho (Chief Legal Officer & CCO)

Insider trade Purchase by Wade Loo

Insider trade Purchase by Robert P Badavas

News Hercules Capital expects robust originations in 2026 amid platform expansion and defensive positioning

Scanner Unusual volume (19.5x average)

News Investment Manager Rebalances, Trims Stake in Hercules Capital

News MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab

Get push alerts for HCXY

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS